Segmental Ureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis of Comparative Studies

医学 优势比 荟萃分析 置信区间 尿路上皮癌 泌尿科 人口 肾积水 膀胱切除术 阶段(地层学) 内科学 膀胱癌 肿瘤科 癌症 泌尿系统 环境卫生 生物 古生物学
作者
Alessandro Veccia,Alessandro Antonelli,Enrico Checcucci,Ugo Giovanni Falagario,Giuseppe Carrieri,Georgi Guruli,Marco De Sio,Claudio Simeone,Francesco Porpiglia,Riccardo Autorino
出处
期刊:Clinical Genitourinary Cancer [Elsevier BV]
卷期号:18 (1): e10-e20 被引量:22
标识
DOI:10.1016/j.clgc.2019.10.015
摘要

Radical nephroureterectomy (RNU) represents the standard of care for high-risk upper tract urothelial carcinoma (UTUC). In selected patients with ureteral UTUC, a conservative approach such as segmental ureterectomy (SU) can be considered. However, this therapeutic option remains controversial. The aim of this study was to perform a systematic review and meta-analysis of studies assessing the outcomes of SU versus RNU in patients with UTUC. Three search engines (Scopus, Embase, and Web of Science) were queried up to May 2019. The Preferred Reporting Items for Systematic Review and Meta-analysis Statement (PRISMA Statement) was used as a guideline for study selection. The clinical question was established as stated in the PICO (Population, Intervention, Comparator, Outcome) process. Patients in the SU group were more likely to have history of bladder cancer (odds ratio [OR], 1.99; 95% confidence interval [CI], 1.12-3.51; P = .02), but less likely to present with preoperative hydronephrosis (OR, 0.52; 95% CI: 0.31-0.88; P = .02). A higher rate of ureteral tumor location was found in the SU group (OR, 7.54; 95% CI, 4.15-13.68; P < .00001). The SU group presented with a lower rate of higher (pT ≥ 2) stage (OR, 0.66; 95% CI, 0.53-0.82; P = .0002), and high-grade tumors (OR, 0.62; 95% CI, 0.50-0.78; P < .0001). The SU group was found to have shorter 5-year relapse-free survival (OR, 0.64; 95% CI, 0.43-0.95; P = .03), but higher postoperative estimated glomular filtration rate (weighted mean difference, 10.97 mL/min; 95% CI, 2.97-18.98; P = .007). Selected patients might benefit from SU as a therapeutic option for UTUC. In advanced high-risk disease, RNU still remains the standard of care.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
XYM发布了新的文献求助10
1秒前
范自然完成签到,获得积分10
1秒前
2秒前
小郑完成签到,获得积分10
2秒前
shuyiWang发布了新的文献求助10
3秒前
3秒前
4秒前
maxiaole的应助被彩色蚂蚁采纳,获得10
4秒前
Owen的应助被魔术师采纳,获得10
5秒前
乐乐的应助被zyt采纳,获得10
5秒前
花朝唯完成签到 ,获得积分10
5秒前
田様的应助被科研通管家采纳,获得10
6秒前
aa的应助被科研通管家采纳,获得10
6秒前
6秒前
小鲸鱼的应助被科研通管家采纳,获得10
6秒前
Criminology34的应助被科研通管家采纳,获得10
6秒前
英俊的铭的应助被科研通管家采纳,获得10
6秒前
null的应助被科研通管家采纳,获得10
7秒前
7秒前
科目三的应助被科研通管家采纳,获得10
7秒前
隐形曼青的应助被科研通管家采纳,获得10
7秒前
程科杰完成签到,获得积分10
7秒前
7秒前
xcgh的应助被科研通管家采纳,获得10
7秒前
英俊的铭的应助被maf2007采纳,获得10
7秒前
达其的应助被科研通管家采纳,获得10
7秒前
烟花的应助被zpctx采纳,获得10
7秒前
顾矜的应助被zpctx采纳,获得10
7秒前
橙子雨完成签到 ,获得积分10
8秒前
9秒前
仁爱的沁发布了新的文献求助50
9秒前
10秒前
xm发布了新的文献求助50
10秒前
11秒前
哈哈兔发布了新的文献求助10
11秒前
顺利的尔冬完成签到,获得积分10
11秒前
慕青的应助被whc采纳,获得10
12秒前
12秒前
13秒前
渝儿完成签到 ,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160632
求助须知:如何正确求助?哪些是违规求助? 9555512
关于积分的说明 21728801
捐赠科研通 7750444
什么是DOI,文献DOI怎么找? 3427429
关于科研通互助平台的介绍 2552456
邀请新用户注册赠送积分活动 2471817